Nexium Φακελίσκοσ (Esomeprazole)

Esomeprazole blocks the gastric H+/K+ ATPase enzyme, also known as the proton pump, located on the surface of stomach parietal cells. This inhibition stops the final step of acid production, leading to a sustained reduction in gastric acid secretion and an increase in gastric pH.

The appropriate dose of Nexium Φακελίσκοσ is determined by a qualified prescriber based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the dosing instructions provided by their healthcare professional.

Safety data for esomeprazole in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Esomeprazole is the S‑enantiomer of omeprazole and generally provides more consistent acid suppression than racemic PPIs. Compared with H2‑receptor antagonists, it offers longer duration of action and greater efficacy for severe acid‑related conditions, though individual response may vary.

Store at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Nexium Φακελίσκοσ is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the specific instructions given by their prescriber regarding timing relative to meals.

Serious adverse events, although rare, include severe allergic reactions, Clostridioides difficile‑associated diarrhoea, low magnesium levels, liver enzyme elevations, Stevens‑Johnson syndrome and acute pancreatitis. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhoea, muscle cramps, jaundice or severe abdominal pain.

Patients with known hypersensitivity to esomeprazole or any component of the formulation should avoid the product. Caution is also advised for individuals with severe liver disease, those on certain interacting medications, and patients requiring long‑term acid suppression without clear indication.